Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Sep 09, 2022 1:59pm
328 Views
Post# 34952717

RE:RE:Probability of Success & Pre-Market Costs of Cancer Drugs

RE:RE:Probability of Success & Pre-Market Costs of Cancer DrugsIt makes complaining about being on the Venture or getting infrequent updates seem a little petty doesn't it. They are doing what they have to do and no amount of complaining can speed up the results. Those that control the price of the stock have recognized the timelines all along, they factored in covid delays and the 12 patients who were under treated, while we looked for relatively meaningless news releases hoping they would boost the price. But it's been about approvals from the FDA all along, BTD and AA, and now we seem to be in a window of 3 to 6 months for one or both.

You are right Skys, they have done everything they can to PROTECT the shareholder with as little dilution as possible. These day to day movements don't mean a thing so let's focus on what they are about to achieve.


skys1 wrote: Totally agree Eoganacht and CancerSlayer. Big Pharma companies spend hundreds of $millions on drugs that go nowhere, yet little TLT with just a few $million has their ACT on the verge of BTD & AA approval. Amazing, all I can say is congrats management on a job well done.


<< Previous
Bullboard Posts
Next >>